Takashi Hatano
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Diagnostic flow analysis of tuberous sclerosis complex in Japan: a retrospective claims database study.
Journal: Orphanet journal of rare diseases
Published: May 20, 2024
Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: March 09, 2023
Therapeutic effect of everolimus on small renal angiomyolipoma in cases of tuberous sclerosis complex-related epilepsy and subependymal giant cell astrocytoma.
Journal: Asian journal of surgery
Published: August 02, 2022
The characteristics and optimal treatment of urolithiasis associated with tuberous sclerosis complex.
Journal: International urology and nephrology
Published: February 18, 2021
Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex.
Journal: International journal of clinical oncology
Published: July 04, 2020
Significant cases of central cusps, enamel pits, and oral fibromas in tuberous sclerosis complex.
Journal: Odontology
Published: April 12, 2020
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex.
Journal: Orphanet journal of rare diseases
Published: March 28, 2020
Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.
Journal: Asian journal of surgery
Published: August 05, 2019
Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.
Journal: International journal of clinical oncology
Published: June 14, 2019
Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma.
Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma.
Journal: Japanese journal of clinical oncology
Published: December 22, 2018
Last Updated: 09/26/2026